# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-24-092644
Filing Date
2024-08-26
Accepted
2024-08-26 08:22:48
Documents
15
Period of Report
2024-08-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2422579d1_8k.htm iXBRL | 8-K | 34455
2 | EXHIBIT 3.1 | tm2422579d1_ex3-1.htm | EX-3.1 | 1266
6 | GRAPHIC | tm2422579d1_ex3-1img001.jpg | GRAPHIC | 495946
| Complete submission text file | 0001104659-24-092644.txt |  | 897492

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | syn-20240822.xsd | EX-101.SCH | 3042
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | syn-20240822_lab.xml | EX-101.LAB | 34240
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | syn-20240822_pre.xml | EX-101.PRE | 22378
17 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2422579d1_8k_htm.xml | XML | 3808

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 241237845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)